Changes in D-dimer and inflammatory biomarkers before ischemic events in patients with peripheral artery disease: The BRAVO Study

Vascular Medicine (United Kingdom)

Volumn 21, Issue 1, 2016, Pages 12-20

  McDermott, Mary McGrae ^a   Liu, Kiang ^a   Green, David ^a   Greenland, Philip ^a   Tian, Lu ^b   Kibbe, Melina ^a,c   Tracy, Russell ^d   Shah, Sanjiv ^a   Wilkins, John T ^a   Huffman, Mark ^a   Zhao, Lihui ^a   Huang, Chiang Ching ^e   Auerbach, Amanda ^a   Liao, Yihua ^a   Skelly, Christopher L ^f   McCarthy, Walter ^g   Lloyd Jones, Donald ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d University of Vermont Colchester Research Facility   (United States)

^e UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^f UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

biomarkers; C reactive protein; cardiovascular mortality; D dimer; ischemic heart disease; peripheral artery disease; risk factors

Indexed keywords

C REACTIVE PROTEIN; D DIMER; SERUM AMYLOID A; AUTACOID; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

AGED; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ARREST; HEART DEATH; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; Q WAVE; RESUSCITATION; SILENT MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; UPREGULATION; BLOOD; CLINICAL TRIAL; DISEASE COURSE; ILLINOIS; METABOLISM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; TIME FACTOR;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; CHICAGO; DISEASE PROGRESSION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; UP-REGULATION;

EID: 84961325892     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X15617541     Document Type: Article

References (37)

1. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013; 382: 1329-1340.
2. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: 143-152.
3. Heald CL, Fowkes FG, Murray GD, et al. Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 2006; 189: 61-69.
4. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197-208.
5. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386.
6. McDermott MM, Guralnik JM, Corsi A, et al. Patterns of inflammation associated with peripheral arterial disease: the inCHIANTI study. Am Heart J 2005; 150: 276-281.
7. McDermott MM, Green D, Greenland P, et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003; 92: 194-199.
8. Moss AJ, Goldstein RE, Marder VJ, et al. Thrombogenic factors and recurrent coronary events. Circulation 1999; 99: 2517-2522.
9. Libby P,. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-372.
10. Libby P, Ridker P, Maseri A,. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
11. McDermott MM, Greenland P, Liu K, et al. Vulnerable blood in high risk vascular patients: study design and methods. Contemp Clin Trials 2014; 38: 121-129.
12. Fried LP, Kasper JD, Williamson JD, et al.; for the Disease Ascertainment Working Group. Disease ascertainment algorithms. In: Guralnik JM, Fried LP, Simonsick EM, (eds) The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. Bethesda, MD: National Institute on Aging, 1995; NIH publication no. 95-4009; Appendix E.
13. McDermott MM, Greenland P, Liu K, et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002; 136: 873-883.
14. McDermott MM, Criqui MH, Liu K, et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg 2000; 32: 1164-1171.
15. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study: methods and initial two years' experience. J Clin Epidemiol 1996; 49: 223-233.
16. Medalie JH, Goldbourt U,. Unrecognized myocardial infarction five-year incidence, mortality, and risk factors. Ann Intern Med 1976; 84: 526-531.
17. Yano K, MacLean CJ,. The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program. Arch Intern Med 1989; 149: 1528-1532.
18. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-881.
19. Sheifer SE, Gersh BJ, Yanez ND III, et al. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. J Am Coll Cardiol 2000; 35: 119-126.
20. ++ method. Clin Chem 1998; 44: 1242-1250.
21. Sugiuchi H, Ugi Y, Okabe H, et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin. Clin Chem 1995; 41: 717-723.
22. Pahor M, Guralnik JM, Ambrosius WT, et al. LIFE study investigators. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 2014; 311: 2387-2396.
23. Ross R,. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
24. Fuster V, Fayad ZA, Badimon JJ,. Acute coronary syndromes: biology. Lancet 1999; 353 (Suppl 2): SII5-9.
25. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-1282.
26. Mann J, Davies MJ,. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999; 82: 265-268.
27. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78: 1157-1166.
28. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
29. Goldstein JA, Demetriou D, Grines CL, et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922.
30. Nissen SE,. Who is at risk for atherosclerotic disease? Lessons from intravascular ultrasound. Am J Med 2002; 112 Suppl 8: 27S-33S.
31. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002; 106: 804-808.
32. Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture. Circ Res 2014; 114: 1852-1866.
33. Pirro M, Bergeron J, Dagenais GR, et al. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 2001; 161: 2474-2480.
34. Jenny NS, Yanez ND, Psaty BM, et al. Inflammation biomarkers and near-term death in older men. Am J Epidemiol 2007; 165: 684-695.
35. Cushman M, Lemaitre RN, Kuller LH, et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493-498.
36. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-1127.
37. Libby P, Pasterkamp G,. Requiem for the 'vulnerable plaque'. Eur Heart J 2015; 36: 2984-2987.